$949 – $2,200

14th International Conference on Virology and Microbiology (CSE)

Event Information

Share this event

Date and Time



Venue will be informed to the Registered Participants

Vancouver, Canada 0000


View Map

Refund Policy

Refund Policy

No Refunds

Event description


14th International Conference on Virology and Microbiology

About us

ConferenceSeries LLC Ltd and its subsidiaries including iMedPub LLC and Conference Series LLC Ltd Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ConferenceSeries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", ConferenceSeries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology journals. ConferenceSeries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. ConferenceSeries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Virology Congress 2019

Conference series LLC Ltdpleased to announce "International Conference on Virology and Microbiology"held during July 26-27, 2018 Vancouver, Canada. We are happy to invite all anticipated participants to share and explore their research findings as Keynote presentations, Oral talks, and Poster presentations, Symposiums, Workshops and Exhibitions.
Conference Name Place Date
Virology Congress 2019 Vancouver, Canada July 26-27, 2019

Virology Congress 2019will focus on the latest and exciting innovations in all areas of Virology and Microbiology research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. ThisVirology Congress 2019 also encourages the active participation of young student researchers as we are hosting Poster Award Competition and Young research Forum at the conference venue. Virology is often considered a part of microbiology or of pathology. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. Viruses and viral diseases have been at the centers of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. The advent of the HIV pandemic led to a dramatic increase in research in the field of rational drug design, resulting in the large number of antiviral drugs and vaccines entering clinical trials today.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B ( 1.1million), Malaria(2.1million), Diarrhea (3.1 million), Tuberculosis (3.1 million), Respiratory Infections (4.4 million).

Target Audience:

· Virology Students, Scientists

· Virology Researchers

· Virology Faculty

· Dean and Directors

· Pharmaceutical Industries

· Microbiologists

· Health Care Professionals

· Bacteriologists

· Epidemiologists

· Virology Associations and Societies

· Doctors

· International AIDS Society

· Infection Prevention and Infection Control Specialists

· Experts and Delegates

· Virologists

· Parasitologists

Why to attend?

Virology Congress 2019provide a global platform for exchanging ideas and make us updated about the New Technologies Emerging in Virology & Microbiology. It is the best Opportunity to attend the presentations delivered by Eminent Scientists from all over the world. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

For Abstract Submission please go through the link:

Why Vancouver?

Vancouver is a coastal seaport city inCanada, located in theLower Mainlandregion ofBritish Columbia. As themost populous cityin the province & one of North America's most cosmopolitan cities. Vancouver as "a world-class city with ocean attached". Stanley Park is one of the world's largest (1,000 acres) and most beautiful urban green spaces. Must-sees include the nine towering totem poles at Brockton Point. TheGreater Vancouverarea had a population of 2,463,431 in 2016, making it thethird-largest metropolitan area in Canada.TheEconomist Intelligence Unitacknowledged it as the first city ranked among the top-ten of the world's most well-living citiesfor five consecutive years.

Vancouver has hosted many international conferences and events, including the1954British Empire and Commonwealth Games,UN Habitat I,Expo 86, theWorld Police and Fire Gamesin 1989 and 2009; and the2010 Winter Olympics andParalympicswhich were held in Vancouver andWhistler, a resort community 125km (78mi) north of the city. The City of Vancouver was one of the first cities in Canada to enter into an international sister cities arrangement.


2019 Upcoming Soon

Day 1 July 27, 2018
Conference Hall: Red Cedar Ballroom C

09:00-09:30 Registrations
09:30-09:45 Opening Ceremony
Keynote Forum
09:45-10:15 Title: Manipulating the immune response to inhibit emerging virus infection
Rongtuan Lin, McGill University, Canada
10:15-10:45 Title: Early proof of concept with human viral challenge models in vaccine
Clayton A Dehn, High Point Clinical Trials, USA
Panel Discussion
Group Photo
Networking & Refreshment Break 10:45-11:00 @ Red Cedar Foyer
11:00-11:30 Title: Interface between bioinformatics and virology
Martin Hölzer, Friedrich Schiller University Jena, Germany
11:30-12:00 Title: A self-adjuvanting vaccine delivery platform with potential to eliminate the coldchain
Yusuf Omosun, Morehouse School of Medicine, USA
12:00-12:30 Title: Challenges and solutions for maintaining quality and potency of the product in
vaccine development
Laura Hong, Merck & Co., Inc., USA
Panel Discussion
Sessions: Vaccine Research & Development| Human Vaccines - Infectious & Non Infectious Diseases | Cancer and
Immunotherapy Vaccine| Viral Infections | Immunology of Infections | Pediatric Infectious Diseases
Session Chair: Bin Lu, Medimmune, USA
Session Introduction
Title: Using monoclonal antibodies as immune correlates of protection: Thermostable ricin toxin
vaccine development
Oreola Donini, Soligenix, Inc., USA
Panel Discussion
Lunch Break 12:55-13:55 @ Red Cedar Foyer
13:55-14:20 Title: Changes to cervical screening in Australia: A strategy for a vaccinated population
Bryan Knight, Southern IML Pathology, Australia
14:20- 14:45
Title: Comparison of three sample size estimation methods for non-inferiority vaccine trials with
multiple continuous co-primary endpoints
Yang Jiaying, Southeast University, China
Title: Molecular analysis of Respiratory Syncytial Virus (Rsv) F and G proteins during the 2015-2017
winter seasons in the USA and viral susceptibility to anti-Rsv monoclonal antibody (mAbs)
Bin Lu, Medimmune, USA
Title: The application of epidemic dynamics on the prediction and prevention of hand-foot-and-mouth
disease (HFMD) induced by EV71 virus
Li Luo, Southeast University, China
Panel Discussion 15:35-15:40
Networking & Refreshment Break 15:40-16:00 @ Red Cedar Foyer
Title: Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrinsmediated
Cd8+ T Cell infiltration to control mucosal tumor growth
Chien-Fu Hung, The Johns Hopkins University, USA
16:25-16:50 Title: Iron responsive-like elements in the parasite Entamoeba histolytica
Claudia León-Sicairos, Universidad Autónoma de Sinaloa, Mexico
Title: Possible role of fibrates in attenuated cardioprotective effect of ischemic preconditioning in
hyperlipidemic condition
Sugga Gurfateh Singh, Rayat-Bahra University, India
17:15-17:40 Title: Disruption of Hpv-16 E1 and E2 regulatory genes as a prognostic factor in cervical cancer
Katarzyna Sitarz, Jagiellonian University Medical College, Poland
Panel Discussion

Day 2 July 28, 2018
Conference Hall: Red Cedar Ballroom C
Keynote Forum
09:30-10:00 Title: The Changing face of TB treatment for people living with HIV/AIDS
Margaret Muthoni Wanyoike, Women Fighting HIV/AIDS in Kenya, Kenya
10:00-10:30 Current scenario of clinical trials in India
Sugga Gurfateh Singh, Rayat Bahra University, India
Panel Discussion
Networking and Refreshment Break 10:30-10:45 @ Red Cedar Foyer
Sessions: Immunology Research |Clinical Trials for Diseases |Case Report in Clinical Trials |Virology Research |
Monoclonal Antibodies
Session Chair: Rongtuan Lin, McGill University, Canada
Session Introduction
10:45-11:10 Title: The current status, challenges and future developments of new tuberculosis vaccines
Wenping Gong, The 309th Hospital of PLA, China
11:10-11:35 Title: Human Herpesvirus type 8 in patients with chronic hepatitis
Cheng-Chuan Su, Tzu Chi University, Taiwan
11:35-12:00 Title: Merkel cell polyomavirus DNA sequences in the blood of healthy population of Pakistan
Naveed Shahzad, University of the Punjab Lahore, Pakistan
Title: Analysis of antimicrobial resistance and risk factors of hospital acquired methicillin-resistant
Staphylococcus aureus infection
Luo Yanping, General Hospital of Chinese PLA, China
Panel Discussion 12:25-12:40
Lunch Break 12:40-13:40 @ Red Cedar Foyer
Poster Session 13:40-14:10
VP 01 Title: Longitudinal evolution of norovirus in chronically infected patients
Suliman Qadir Afridi, Technische Universität München, Germany
VP 02 Title: Epidemiological study of cutaneous leishmaniases in cities of Kermanshah province, Iran
Naser Nazari, Kermanshah University of Medical Sciences, Iran
VP 03
Title: The main pathogenic bacteria distribution and drug resistance analysis of common surgical
infection in general surgery
Zhang Youjiang, General Hospital of Chinese PLA, China
VP 04 Zübeyde Yılmaz, Turkey
VP 05
Title: Development of hepatitis B virus large surface protein pre-S2 mutant ELISA assay for predicting
hepatoma risk in chronic carriers
Wenya Huang, National Cheng Kung University, Taiwan
Speaker Session
Title: Role of treatment supporter in control of T.B through T.B control program working in district
Sargodha Punjab Pakistan
Iqbal Sami, TB Hospital Sardogha, Pakistan
14:35-15:00 Title: The role of Hpv in esophageal squamous cell carcinoma (escc) in north of Iran
Zeinab Hedayati, Port Moody Secondary School, Canada
Video Presentations
Title: Cell tropism of drug-naïve HIV-individuals infected with HIV-1 subtype A6 at late stages of the
Marina N Nosik, Mechnikov Research Institute of Vaccines and Sera, Russia
15:15-15:30 Title: Emerging H1N1 Influenza A Virus and its specific prevention
Giulio Filippo Tarro, World Academy Biomedical Technologies, Italy
Panel Discussion
Networking and Refreshment Break 15:30-15:50 @ Red Cedar Foyer
Thanks Giving & Closing Ceremony

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship

Prices may go up any time. Service fees included in pricing.
This event is brought to you by:
Conference Series - NewYorkEventsList


Share with friends

Date and Time


Venue will be informed to the Registered Participants

Vancouver, Canada 0000


View Map

Refund Policy

No Refunds

Save This Event

Event Saved